HOME > TOP STORIES
TOP STORIES
-
REGULATORY Outgoing Chair of Unapproved Drug Council Boasts 300 Approvals Achieved to Cut Lag, Urges New Reimbursement Scheme
March 4, 2022
-
BUSINESS AZ Japan Working towards 100% Electric Vehicle Fleet by 2025, but Challenges Remain
March 3, 2022
-
REGULATORY Alexion’s Bleeding Antidote Up for PAFSC Discussion Again after Data Integrity Issues
March 3, 2022
-
BUSINESS Zogenix Sees Its Pipeline Drugs Continue to Be Developed in Japan after UCB Deal
March 2, 2022
-
BUSINESS Drugs Might Get Hit by SWIFT Ban on Russia Even If Exempted from Trade Sanctions
March 1, 2022
-
BUSINESS Ono Sues AstraZeneca over PD-L1 Patent, Seeks 32 Billion Yen in Damage
March 1, 2022
-
REGULATORY MHLW Approves Label Expansions for Retevmo, Keytruda, Lenvima and More
February 28, 2022
-
ORGANIZATION Impact of Ukraine Invasion Limited in Japan? Trader Group Says Epirubicin Is Only API Possibly Affected
February 25, 2022
-
BUSINESS Tokyo Court Rejects Chugai’s Claim over Edirol Substance Patent
February 25, 2022
-
BUSINESS Medicago’s COVID-19 Vaccine Approved in Canada
February 25, 2022
-
ORGANIZATION Chuikyo Payer Rep Wants Category-Based Debate on Adjustment Rate, Prods PMP Cuts in Next Off-Year Revision
February 24, 2022
-
BUSINESS Bayer Gets Eylea Biosame Approval in Japan as It Braces for Biosimilar Debuts
February 22, 2022
-
BUSINESS Sleep Inducer Recalls by Fuji Yakuhin, Tatsumi Kagaku Tied to Tokyo Wholesaler’s Fake API Case
February 21, 2022
-
REGULATORY Japan Weighs Pre-Approval Purchase of Shionogi’s COVID-19 Pill
February 21, 2022
-
BUSINESS Chugai Claims 1st-Ever Title in Japan Pharma Market in 2021 on Brisk Oncologic Performance: IQVIA
February 18, 2022
-
BUSINESS Sawai to Launch Teribone Generic as Court Invalidates Patents; Asahi Kasei to Challenge Ruling
February 17, 2022
-
REGULATORY Japan Approves Slew of Generics towards June Listing; Samsca, Xarelto AGs Too
February 16, 2022
-
BUSINESS Pharma Officials Air Hopes and Concerns as Japan Moves to Enhance Supply Chain for Economic Security
February 15, 2022
-
REGULATORY Japan Snags 10 Million Extra Doses of Pfizer Vaccine
February 15, 2022
-
BUSINESS Chugai Joins Top Ranks in Japan Sales on Ronapreve Boon, Roche Collaboration
February 14, 2022
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
